Concepedia

Publication | Closed Access

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

138

Citations

25

References

2018

Year

References

YearCitations

2009

60.7K

2008

28.6K

2010

12.5K

1955

5.9K

2013

5.6K

2012

5.2K

2009

2.8K

2011

678

2001

430

2011

333

Page 1